Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Game theory explains why reasonable parents make vaccine choices that fuel outbreaks - 2Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
- 3Kiev declares energy emergency after Russian attacks amid winter cold
- 4Oil magnate’s Venezuela detainment spooks industry
- 5Civil rights leader Jesse Jackson hospitalized, family requests prayers
- 3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
- Vacuum Cleaners That Are Not difficult To Use For Home
- The hunt for dark matter: a trivia quiz
- Traveling Alone: An Excursion of Self-Disclosure
- Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Some gifted dogs can learn new toy names by eavesdropping on owners
- Vote in favor of your Number one natural product
- The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind
